Guidewires distributed by Covidien undergo a recall after manufacturer Nitinol Devices & Components received a dozen customer complaints.
Seven questions raised by the pending merger between medical device giants Medtronic and Covidien, valued at $43 billion.
Political leaders in Massachusetts hope for the best from Medtronic's acquisition of Covidien, but say they've had no contact with either company on potential job losses in the Bay State or anything else.
This week is all about Medtronic's blockbuster acquisition of Covidien for nearly $43 billion and the deal's wider implications for medtech; plus, Hill-Rom makes a move in Germany.
LifeScience Alley CEO Shaye Mandle writes that the recently announced marriage of Medtronic and Covidien is a boon for the North Star State.
By: Shaye Mandle, President & CEO, LifeScience Alley
LifeScience Alley, the nation's largest regional life science industry association, welcomes the news that Medtronic, the world’s leading provider of medical technology products, services and solutions, is acquiring Covidien, a leading global healthcare technology and medical supplies provider.
Medtronic's pending $43 billion acquisition of Covidien could trigger 'golden parachute' provisions worth nearly $80 million for Covidien's senior management team.
If the top executives at Covidien decide to leave the company after a $43 billion acquisition by Medtronic goes through, they'll do it under a golden parachute worth a collective $80 million, regulatory filings show.
Medtronic's pending acquisition of Covidien will see the company's headquarters moved to Ireland, and one political hopeful is blaming the Obama Administration for chasing innovation out of the U.S.